Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.

Saved in:
Bibliographic Details
Title: Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.
Authors: Honig, Lawrence S.1 lh456@cumc.columbia.edu, Vellas, Bruno2, Woodward, Michael3,4, Boada, Merce5, Bullock, Roger6, Borrie, Michael7, Hager, Klaus8, Andreasen, Niels9, Scarpini, Elio10, Liu-Seifert, Hong11, Case, Michael11, Dean, Robert A.12, Hake, Ann, Sundell, Karen11, Hoffmann, Vicki Poole11, Carlson, Christopher11, Khanna, Rashna, Mintun, Mark11,13, DeMattos, Ronald11, Selzler, KatherineJ.11
Source: New England Journal of Medicine. 1/25/2018, Vol. 378 Issue 4, p321-330. 10p.
Database: Academic Search Ultimate
Description
ISSN:00284793
DOI:10.1056/NEJMoa1705971